Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Pain ; 122(1-2): 174-81, 2006 May.
Article in English | MEDLINE | ID: mdl-16545911

ABSTRACT

Patients with bone cancer report severe pain and receive mu-opioids. We developed a family of peptidomimetic delta-agonists, one of which H2N-Tyr-dVal-Gly-Phe-Ala-OH ([dVal(L)2,Ala(L)5]E) binds with a 1700x affinity at the delta versus mu receptor. To examine the systemic analgesic efficacy of this delta-agonist versus morphine in osteosarcoma pain, osteosarcoma cells are injected into one femur of the anesthetized mouse. After 10-18 days, a decalcification of the injected femur occurs along with a pronounced tactile allodynia. IP morphine and [dVal(L)2,Ala(L)5]E produced a dose-dependent reversal of allodynia with the respective ED50 values being 5.3+/-1.9 mg/kg for morphine and 1.3+/-0.3 mg/kg for [dVal(L)2,Ala(L)5]E. Plotting peak effect versus area under the analgesic curve for doses of morphine and [dVal(L)2,Ala(L)5]E revealed overlapping curves suggesting that for a given effect, [dVal(L)2,Ala(L)5]E produced a similar duration of action as morphine. These effects were reversed by IP naloxone (3 mg/kg). IP naltrindole (1 mg/kg) preferentially reversed [dVal(L)2,Ala(L)5]E. The upper dose effects of morphine but not [dVal(L)2,Ala(L)5]E were limited by pronounced hyperactivity. No other effects were noted. These results show that IP [dVal(L)2,Ala(L)5]E through a delta receptor produces analgesia equal in efficacy to that of morphine but with a 4.5-fold greater potency. Over the doses examined, morphine actions were side effect limited. The delta side effects were not so limited, suggesting a favorable therapeutic ratio for delta-agonists in this pain model. These studies suggest that a systemically delivered delta-opioid agonist has pronounced analgesic properties on a preclinical cancer pain model.


Subject(s)
Analgesics/administration & dosage , Bone Neoplasms/complications , Hyperalgesia/prevention & control , Osteosarcoma/drug therapy , Pain Threshold/drug effects , Receptors, Opioid, delta/agonists , Animals , Arthralgia/etiology , Arthralgia/physiopathology , Arthralgia/prevention & control , Bone Neoplasms/drug therapy , Bone Neoplasms/physiopathology , Dose-Response Relationship, Drug , Hyperalgesia/etiology , Hyperalgesia/physiopathology , Male , Mice , Mice, Inbred C3H , Morphine/administration & dosage , Osteosarcoma/complications , Osteosarcoma/physiopathology , Touch , Treatment Outcome
2.
Org Lett ; 7(20): 4309-12, 2005 Sep 29.
Article in English | MEDLINE | ID: mdl-16178520

ABSTRACT

[reaction: see text] The tricyclic indeno-tetrahydropyridine core of haouamine A, containing five of the seven rings of the natural product, was constructed by a simple, concise route that features an acid-catalyzed Friedel-Crafts ring closure.


Subject(s)
Heterocyclic Compounds, 4 or More Rings/chemical synthesis , Indenes/chemistry , Pyridines/chemistry , Heterocyclic Compounds, 4 or More Rings/chemistry , Indenes/chemical synthesis , Molecular Structure , Pyridines/chemical synthesis
3.
Org Lett ; 7(2): 255-8, 2005 Jan 20.
Article in English | MEDLINE | ID: mdl-15646971

ABSTRACT

[Reaction: see text] Enantiocontrolled synthesis of alpha-methyl amino acids proceeds via the regioselective organocuprate opening of Bn2N-alpha-methylserine-beta-lactone. From this chiral intermediate, a wide variety of alpha-methyl amino acids and building blocks were synthesized in excellent yields.


Subject(s)
Amino Acids/chemistry , Amino Acids/chemical synthesis , Lactones/chemistry , Methane/chemistry , Serine/analogs & derivatives , Molecular Structure , Serine/chemistry , Stereoisomerism
4.
J Pept Sci ; 9(9): 594-603, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14552421

ABSTRACT

A century has passed since Emil Fischer won the Nobel Prize in chemistry. From his first synthesis of glycyl-glycine in 1901 he has been a luminary to peptide chemists over the past 100 years. In this paper, a brief summary of some of the major accomplishments in peptide chemistry will be covered followed by a description of several of our own endeavours in peptide chemistry which arose from the discoveries of the giants of our field. We will include the development of a novel activating agent (DEPBT), the synthesis of a novel building block, alpha-methyl-D-cysteine, its incorporation into biologically active opioids, and conclude with the synthesis of dendritic collagen mimetics.


Subject(s)
Peptides/chemical synthesis , Peptides/history , Collagen/chemistry , History, 20th Century , History, 21st Century , Molecular Mimicry , Molecular Structure , Nobel Prize , Opioid Peptides/chemistry , Organophosphates/chemistry , Peptides/chemistry , Triazines/chemistry
5.
Org Lett ; 5(7): 1035-7, 2003 Apr 03.
Article in English | MEDLINE | ID: mdl-12659567

ABSTRACT

[reaction: see text] We report here the enantioselective synthesis of Boc-alpha-methyl-d-cysteine(PMB)-OH and lanthionine building blocks through the regioselective ring opening of key intermediate Boc-alpha-methyl-d-serine-beta-lactone.


Subject(s)
Alanine/analogs & derivatives , Alanine/chemical synthesis , Cysteine/analogs & derivatives , Cysteine/chemical synthesis , Lactones/chemistry , Lactones/chemical synthesis , Serine/chemical synthesis , Alanine/chemistry , Cysteine/chemistry , Models, Molecular , Molecular Conformation , Molecular Structure , Serine/analogs & derivatives , Serine/chemistry , Sulfides
SELECTION OF CITATIONS
SEARCH DETAIL
...